BML Pharmaceuticals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

BML Pharmaceuticals General Information

Description

Developer of proprietary prescriptive pharmaceutical products in the areas of cancer treatment. The company's products are formulated into therapeutics which range from the prevention and treatment of dermal disease to mucositis for cancer patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 1129 Northern Boulevard
  • Suite 406
  • Manhasset, NY 11030
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BML Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial

BML Pharmaceuticals Patents

BML Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2002332927-A1 Method of preventing mucositis Inactive 06-Sep-2001 000000000
AU-2002332927-A8 Method of preventing mucositis Inactive 06-Sep-2001 000000000
US-20030059378-A1 By applying to oral, pharyngeal, esophogeal, gastrointestinal and other mucosal tissues triclosan alone or in combination with a cationic agent such as chlorhexidine or benzalkonium chloride; for immunocompromised patients Inactive 06-Sep-2001 000000000
US-20020187107-A1 Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. Active 08-May-2001 00000000
US-6537526-B2 Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. Inactive 08-May-2001 A61K8/90 00
To view BML Pharmaceuticals’s complete patent history, request access »

BML Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Barry Libin Chairman & Chief Executive Officer
To view BML Pharmaceuticals’s complete executive team members history, request access »

BML Pharmaceuticals Board Members (1)

Name Representing Role Since
00000 00000 Self Chairman & Chief Executive Officer 000 0000
To view BML Pharmaceuticals’s complete board members history, request access »

BML Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial

BML Pharmaceuticals FAQs

  • When was BML Pharmaceuticals founded?

    BML Pharmaceuticals was founded in 1996.

  • Who is the CEO of BML Pharmaceuticals?

    Barry Libin is the CEO of BML Pharmaceuticals.

  • Where is BML Pharmaceuticals headquartered?

    BML Pharmaceuticals is headquartered in Manhasset, NY.

  • What industry is BML Pharmaceuticals in?

    BML Pharmaceuticals’s primary industry is Drug Discovery.

  • Is BML Pharmaceuticals a private or public company?

    BML Pharmaceuticals is a Private company.

  • What is the current valuation of BML Pharmaceuticals?

    The current valuation of BML Pharmaceuticals is 0000.

  • What is BML Pharmaceuticals’s current revenue?

    The current revenue for BML Pharmaceuticals is 000000.

  • Who are BML Pharmaceuticals’s investors?

    Antares Capital (Florida) has invested in BML Pharmaceuticals.

  • When was BML Pharmaceuticals acquired?

    BML Pharmaceuticals was acquired on 29-Jul-2002.

  • Who acquired BML Pharmaceuticals?

    BML Pharmaceuticals was acquired by Endo International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »